According to an analysis conducted by the healthcare advocacy organization Families USA, an estimated 5.5 million Americans who lost their jobs also lost their health insurance. Among the states stricken the worst by a lack of healthcare coverage are Florida, California, Texas, North Carolina and New York. According to the Kaiser Family Foundation, a more […]
Post Type Archives: Blog
Researchers Screen First Participant in Drug Study to Prevent Early Alzheimer’s
Researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) have recently screened the first participant of the AHEAD 3-45 study. This study is aimed at determining whether a medication known as BAN2401 can help prevent cognitive decline and worsening memory in individuals who may be at risk. The AHEAD study is a Phase […]
Hidden in Plain Sight: an Alzheimer’s Reversal Agent
Alzheimer’s Disease has heretofore never had a cure. We use drugs such as donepezil to slow its progress, but we cannot reverse the damage done. Alzheimer’s is the leading cause of dementia in elderly patients and progresses by the congregation of certain peptides in the brain, which connect to form insoluble strands in plaques within […]
Future: Reducing Rate of Mosquito-Borne Diseases through Genetic Engineering
West Nile Virus, Malaria, Dengue Fever; some of the potentially fatal illnesses humans can receive from mosquitos. For years, efforts to combat the spread of these diseases have been focused on secondary and tertiary disease prevention, which focus on early detection and proper response to progressed infection, respectively. Primary prevention strategies, which offer the best […]
Moderna’s COVID-19 Vaccine Spurs Immune Response in Trial
Developers claim that a trial vaccine aimed at fighting COVID-19 has prompted an immune response in healthy adults. The vaccine produces antibodies that can neutralize the novel coronavirus. Final testing will take place this fall, and the government hopes to have final trial results by the end of the year 2020. This would be a […]
Biogen Seeks FDA Approval for First Drug Aimed at Slowing Alzheimer’s Disease
Biogen announced on July 8, 2020 that the company is seeking U.S. approval for the drug aducanumab. If granted approval by the Food and Drug Administration (FDA), the drug would be the first one on the market to slow the progression of Alzheimer’s disease. Biogen claims that aducanumab removes beta amyloid beta which improves clinical […]
A Potential Repurposing of Existing Drugs to Combat Covid-19
In June of 2020, researchers from University of Arizona, University of South Florida Morsani College of Medicine, and Utah State University published an article through Nature titled “Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease”. Their goal was aligned with that of many of today’s researchers: […]
COVID-19: Melatonin as a potential adjuvant treatment
There are researches showing that melatonin has positive effects in alleviating acute respiratory stress induced by virus, bacteria, radiation, etc. This paper reviews evidence indicating melatonin also helps relieve COVID-19 induced pneumonia, acute lung injury and acute respiratory distress syndrome. SARS-CoV-2 infected patients show symptoms of fever, dry cough, myalgia, fatigue, and diarrhea, etc. Examination […]
Post-Intensive Care Syndrome in Geriatric Patients Recovering from COVID-19
Intensive care units see on average 19 million patients admitted each year, a statistic recorded prior to the outbreak of the SARS-CoV-2 coronavirus pandemic this year, which has since only increased this number. Much research has been done looking at short-term acute care and survival outcomes of this life-threatening virus with potential to cause severe […]
Staring at a Deep Red Light Can Significantly Improve Declining Eyesight
A new study finds that staring at a deep red light for three minutes a day can significantly improve declining eyesight. This study, led by University College London (UCL) and published in the Journals of Gerontology, is the first of its kind and scientists believe it could possibly lead to affordable home-based therapies for millions […]